MyHeritage has appointed Yaniv Erlich as chief science officer. He will lead the company's scientific development and strategy for its MyHeritage DNA service. Erlich comes to MyHeritage from Columbia University, where he served as assistant professor of computer science and computational biology. He has also served as a core member of the New York Genome Center, the principal investigator and Whitehead Fellow at MIT's Whitehead Institute, founder of DNA.LAND, and the principal investigator of the Erlich DNA lab.
10x Genomics has appointed Bradford Crutchfield to the position of chief commercial officer, replacing John Pouk, who had been serving as the company's interim CCO. Pouk will stay on as senior vice president of commercial operations. Crutchfield previously served as senior vice president of Qiagen's life sciences business. He has also served as vice president and general manager of Illumina's Europe, Middle East, and Africa operations, as director of NanoString Technologies, and in various roles at Bio-Rad Laboratories.
Veritas Genetics has appointed Birgit Funke as VP of clinical affairs. Funke is a board-certified molecular geneticist and serves as an associate professor of pathology at Harvard Medical School. In addition to her new appointment with Veritas, she will continue her work at Partners Healthcare's Laboratory of Molecular Medicine. Funke also serves as co-chair of ClinGen's Cardiovascular Domain Working Group, as chair of the genetics subdivision of the Association for Molecular Pathology, as advisor on next-generation sequencing for the US Food and Drug Administration, and as a member of the College of American Pathologists' Next-Generation Sequencing Project Team.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.